Skip to Content

Dolutegravir

In the US, Dolutegravir (dolutegravir systemic) is a member of the drug class integrase strand transfer inhibitor and is used to treat HIV Infection.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AX12

CAS registry number (Chemical Abstracts Service)

1051375-16-6

Chemical Formula

C20-H19-F2-N3-O5

Molecular Weight

419

Therapeutic Category

HIV integrase inhibitor

Chemical Names

(4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide (WHO)

2H-Pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-,(4R,12aS)- (USAN)

Foreign Names

  • Dolutegravirum (Latin)
  • Dolutegravir (German)
  • Dolut├ęgravir (French)
  • Dolutegravir (Spanish)

Generic Names

Brand Names

  • Tivicay
    Glaxo Group, Slovakia; Glaxo Wellcome, United States; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Israel; GlaxoSmithKline, Malaysia; ViiV, Hungary; ViiV Healthcare, Switzerland; ViiV Healthcare, Germany; ViiV Healthcare, Greece; ViiV Healthcare, Italy; ViiV Healthcare, Norway; ViiV Healthcare, Poland; ViiV Healthcare, Romania; ViiV Healthcare, Slovenia; ViiV Healthcare UK Limited, Iceland; Wellcome Limited, Bosnia & Herzegowina
  • Triumeq (Dolutegravir and Abacavir, + Lamivudine)
    ViiV Healthcare, Germany; ViiV Healthcare, Slovenia
  • Tivicay
    GlaxoSmithKline, Chile; GlaxoSmithKline, Finland; GlaxoSmithKline, Sweden; ViiV, Belgium; ViiV Healthcare, Austria; ViiV Healthcare, France; ViiV Healthcare, Ireland; ViiV Healthcare, Japan; ViiV Healthcare UK, United Kingdom; ViiV Healthcare ULC, Canada
  • Triumeq (Dolutegravir and Abacavir, + Lamivudine)
    GlaxoSmithKline, Chile; GlaxoSmithKline, Finland; GlaxoSmithKline, Sweden; ViiV, Belgium; ViiV Healthcare, Switzerland; ViiV Healthcare, France; ViiV Healthcare, Ireland; ViiV Healthcare, United States; ViiV Healthcare UK, United Kingdom

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide